A study by Su et al. published in 2020 demonstrated its usefulness in ovarian cancer, where it acted as a potent inhibitor of cell growth and migration in ovarian cancer cells through the suppression of mTOR activation and hypoxia-inducible factor 1-alpha (HIF1α) induction. The gene discussed is MTOR; the disease is ovarian cancer.